This test uses Polymerase Chain Reaction (PCR) technology for the qualitative detection of Epstein-Barr Virus (EBV) DNA in clinical samples such as blood serum, plasma, or body tissues. The detection of viral DNA is a direct indicator of the virus's presence and active replication, being more significant than antibodies in determining active infection, especially in immunocompromised patients.